Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Frailty is an intermediate status of the human aging process, associated with decompensated homeostasis and death. The immune phenotype of frailty and its underlying cellular and molecular processes remain poorly understood. We profiled 114,467 immune cells from cord blood, young adults and healthy and frail old adults using single-cell RNA and TCR sequencing. Here we show an age-dependent accumulation of transcriptome heterogeneity and variability in immune cells. Characteristic transcription factors were identified in given cell types of specific age groups. Trajectory analysis revealed cells from non-frail and frail old adults often fall into distinct paths. Numerous TCR clonotypes were shared among T-cell subtypes in old adults, indicating differential pluripotency and resilience capabilities of aged T cells. A frailty-specific monocyte subset was identified with exclusively high expression of long noncoding RNAs NEAT1 and MALAT1. Our study discovers human frailty-specific immune cell characteristics based on the comprehensive dimensions in the immune landscape of aging and frailty.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s43587-022-00198-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimizing care transitions to post-acute care following hospitalization for people with opioid use disorder.
Innov Aging
August 2025
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, United States.
Background And Objectives: Increased referrals to skilled nursing facilities (SNFs) from hospitalized people with opioid use disorder (OUD) carry risk for financial, safety, and legal consequences for poor transitions in care. We aimed to better understand the hospital to SNF referral process and identify opportunities to improve transitions and care for people with OUD, an increasing share of whom are older adults.
Research Design And Methods: Participants included administrative, executive leadership, and clinical staff involved in SNF admission decisions across the United States.
Aging-associated DNA methylation of LEF1 modulates inflammation and neurodegenerative pathways.
Front Immunol
September 2025
Department of Blood Transfusion, Huashan Hospital, Fudan University, Shanghai, China.
Background: Aging is accompanied by profound changes in immune regulation and epigenetic landscapes, yet the molecular drivers underlying these alterations are not fully understood.
Methods: Transcriptional profiles of peripheral blood samples from young and elderly individuals, together with aging-associated methylation probe data, were used to identify aging biomarkers. Transcriptomics and chromatin immunoprecipitation sequencing (ChIP-Seq) were conducted to explore potential regulatory mechanisms.
The Human Cardiac "Age-OME": Age-Specific Changes in Myocardial Molecular Expression.
Aging Cell
September 2025
School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Ageing is one of the most significant risk factors for heart disease; however, it is still not clear how the human heart changes with age. Taking advantage of a unique set of pre-mortem, cryopreserved, non-diseased human hearts, we performed omics analyses (transcriptomics, proteomics, metabolomics, and lipidomics), coupled with biologically informed computational modelling in younger (≤ 25 years old) and older hearts (≥ 50 years old) to describe the molecular landscape of human cardiac ageing. In older hearts, we observed a downregulation of proteins involved in calcium signalling and the contractile apparatus.
View Article and Find Full Text PDFDispensing Patterns of Prescription Medicines Among Older Australians From 2013-2023.
J Am Med Dir Assoc
September 2025
Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Western Australia, Australia.
Objectives: To characterize annual trends in prescription medicine dispensing patterns among Australians ≥65 years of age from 2013-2023.
Design: Population-based retrospective descriptive study.
Setting And Participants: A 10% sample of the Australian Pharmaceutical Benefits Scheme (PBS) dataset covering medicines dispensed between 2013 and 2023.
Therapeutics Update in Immune Mediated Rheumatic Diseases: Rheumatoid Arthritis, Idiopathic Inflammatory Myositis and ANCA Associated Vasculitis.
Clin Med (Lond)
September 2025
Rheumatology Research Group, Department of Inflammation and Ageing, College of Medicine & Health, University of Birmingham, Birmingham, UK.; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Immune-mediated inflammatory diseases (IMIDs) are a group of common clinically diverse conditions which are characterised by systemic inflammation. They often pose medical challenges due to their multi organ involvement, chronicity, associated co-morbidities and poor impact on quality of life to patients. The management for IMIDs has changed profoundly over the past twenty years with the paradigm of treatment shifting away from broad immunosuppression towards pathway specific targeted treatment.
View Article and Find Full Text PDF